Ted Love, now the chair of biotech’s big trade group, talks drug access, leadership and ‘crazy’ co-pays

Love was CEO of sickle cell disease drug maker Global Blood Therapeutics in San Francisco before its acquisition last year by Pfizer. He begins his two-year stint as chair of BIO’s board at a critical time for the life sciences industry.